Literature DB >> 32360820

Colorectal Dysplasia and Cancer in Pediatric-Onset Ulcerative Colitis Associated With Primary Sclerosing Cholangitis.

Wael El-Matary1, Stephen L Guthery2, Achiya Z Amir3, Matthew DiGuglielmo4, Laura G Draijer5, Katryn N Furuya6, Nitika Gupta7, Jessica T Hochberg8, Simon Horslen9, Nanda Kerkar10, Bart G P Koot5, Trevor J Laborda2, Kathleen M Loomes11, Cara Mack12, Mercedes Martinez13, Alexander Miethke14, Tamir Miloh8, Douglas Mogul15, Saeed Mohammed16, Stacy Moroz17, Nadia Ovchinsky18, Emily R Perito19, Girish Rao20, Amanda Ricciuto21, Pushpa Sathya22, Kathleen B Schwarz23, Uzma Shah24, Ruchi Singh14, Nisreen Soufi17, Pamela L Valentino25, Andréanne Zizzo26, Mark R Deneau2.   

Abstract

Inflammatory bowel disease (IBD), especially when associated with primary sclerosing cholangitis (PSC), is a risk factor for developing colorectal cancer (CRC).1-3 We aimed to determine the incidence of CRC in a large cohort of pediatric-onset PSC-ulcerative colitis (UC) patients.
Copyright © 2021 AGA Institute. All rights reserved.

Entities:  

Mesh：

Year:  2020        PMID： 32360820      PMCID： PMC8788582          DOI： 10.1016/j.cgh.2020.04.055

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN： 1542-3565            Impact factor:   11.382


  6 in total

1.  The natural history of primary sclerosing cholangitis in 781 children: A multicenter, international collaboration.

Authors:  Mark R Deneau; Wael El-Matary; Pamela L Valentino; Reham Abdou; Khaled Alqoaer; Mansi Amin; Achiya Z Amir; Marcus Auth; Fateh Bazerbachi; Annemarie Broderick; Albert Chan; Jillian Cotter; Sylvia Doan; Mounif El-Youssef; Federica Ferrari; Katryn N Furuya; Madeleine Gottrand; Frederic Gottrand; Nitika Gupta; Matjaz Homan; Binita M Kamath; Kyung Mo Kim; Kaija-Leena Kolho; Anastasia Konidari; Bart Koot; Raffaele Iorio; Oren Ledder; Cara Mack; Mercedes Martinez; Tamir Miloh; Parvathi Mohan; Niamh O'Cathain; Alexandra Papadopoulou; Amanda Ricciuto; Lawrence Saubermann; Pushpa Sathya; Eyal Shteyer; Vratislav Smolka; Atushi Tanaka; Raghu Varier; Veena Venkat; Bernadette Vitola; Miriam B Vos; Marek Woynarowski; Jason Yap; M Kyle Jensen
Journal:  Hepatology       Date:  2017-06-26       Impact factor: 17.425

2.  High Risk of Advanced Colorectal Neoplasia in Patients With Primary Sclerosing Cholangitis Associated With Inflammatory Bowel Disease.

Authors:  Shailja C Shah; Joren R Ten Hove; Daniel Castaneda; Carolina Palmela; Erik Mooiweer; Jean-Frédéric Colombel; Noam Harpaz; Thomas A Ullman; Ad A van Bodegraven; Jeroen M Jansen; Nofel Mahmmod; Andrea E van der Meulen-de Jong; Cyriel Y Ponsioen; Christine J van der Woude; Bas Oldenburg; Steven H Itzkowitz; Joana Torres
Journal:  Clin Gastroenterol Hepatol       Date:  2018-03-15       Impact factor: 11.382

3.  Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis.

Authors:  Roy M Soetikno; Otto S Lin; Paul A Heidenreich; Harvey S Young; Michael O Blackstone
Journal:  Gastrointest Endosc       Date:  2002-07       Impact factor: 9.427

4.  High lifetime risk of cancer in primary sclerosing cholangitis.

Authors:  Marian M H Claessen; Frank P Vleggaar; Kristien M A J Tytgat; Peter D Siersema; Henk R van Buuren
Journal:  J Hepatol       Date:  2008-10-14       Impact factor: 25.083

5.  Malignancy and mortality in paediatric-onset inflammatory bowel disease: a 3-year prospective, multinational study from the paediatric IBD Porto group of ESPGHAN.

Authors:  M E Joosse; M A Aardoom; P Kemos; D Turner; D C Wilson; S Koletzko; J Martin-de-Carpi; U L Fagerberg; C Spray; C Tzivinikos; M Sladek; R Shaoul; E Roma-Giannikou; J Bronsky; D E Serban; F M Ruemmele; H Garnier-Lengline; G Veres; I Hojsak; K L Kolho; I H Davies; M Aloi; P Lionetti; S Hussey; G Veereman; C P Braegger; E Trindade; A V Wewer; A C Hauer; A C H de Vries; R Sigall Boneh; C Sarbagili Shabat; A Levine; L de Ridder
Journal:  Aliment Pharmacol Ther       Date:  2018-07-08       Impact factor: 9.524

6.  Gamma Glutamyltransferase Reduction Is Associated With Favorable Outcomes in Pediatric Primary Sclerosing Cholangitis.

Authors:  Mark R Deneau; Cara Mack; Reham Abdou; Mansi Amin; Achiya Amir; Marcus Auth; Fateh Bazerbachi; Anne Marie Broderick; Albert Chan; Matthew DiGuglielmo; Wael El-Matary; Mounif El-Youssef; Federica Ferrari; Katryn N Furuya; Frederic Gottrand; Nitika Gupta; Matjaž Homan; M K Jensen; Binita M Kamath; Kyung Mo Kim; Kaija-Leena Kolho; Anastasia Konidari; Bart Koot; Raffaele Iorio; Mercedes Martinez; Parvathi Mohan; Sirish Palle; Alexandra Papadopoulou; Amanda Ricciuto; Lawrence Saubermann; Pushpa Sathya; Eyal Shteyer; Vratislav Smolka; Atsushi Tanaka; Pamela L Valentino; Raghu Varier; Veena Venkat; Bernadette Vitola; Miriam B Vos; Marek Woynarowski; Jason Yap; Tamir Miloh
Journal:  Hepatol Commun       Date:  2018-09-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.